Juan Roberto
Rodríguez Madoz
Profesional Investigador
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red de Cáncer (11)
2024
-
Rna-loaded nanoparticles for the treatment of hematological cancers
Advanced Drug Delivery Reviews, Vol. 214
-
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model
Journal for immunotherapy of cancer, Vol. 12, Núm. 7
2023
-
FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma
Molecular Therapy, Vol. 31, Núm. 1, pp. 48-65
-
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
Frontiers in Immunology, Vol. 14
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
-
Revealing cell populations catching the early stages of human embryo development in naive pluripotent stem cell cultures
Stem Cell Reports, Vol. 18, Núm. 1, pp. 64-80
2022
-
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Science Advances, Vol. 8, Núm. 39
-
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Molecular Therapy - Methods and Clinical Development, Vol. 25, pp. 137-146
-
One-Step In Vitro Generation of ETV2-Null Pig Embryos
Animals, Vol. 12, Núm. 14
-
SimiC enables the inference of complex gene regulatory dynamics across cell phenotypes
Communications Biology, Vol. 5, Núm. 1
2020
-
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Genome Research, Vol. 30, Núm. 9, pp. 1217-1227